Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Bowling Green › NPI 1871547703
Hospital

Greenview Hospital, INC.

Greenview Hospital, INC. was paid $49.12M by Medicaid between Jan 2018 and Dec 2024, across 222 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoGREENVIEW HOSPITAL, INC.
BOWLING GREEN, KY 42104
33aNPI1871547703assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$49.12M
24GClaims833,903
24DCodes billed222
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#14 of 36
Median peer was paid$36.08M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018140,662$8.09M
2019127,705$7.77M
2020104,356$5.81M
2021115,106$6.40M
2022115,502$6.97M
2023129,534$7.95M
2024incomplete101,038$6.12M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 59,362 52,698 $10.72M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 43,576 37,820 $10.47M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7.3% 27,543 23,010 $3.59M
74176 Computed tomography, abdomen and pelvis; without contrast material 6.8% 9,344 7,399 $3.32M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.4% 6,406 5,303 $2.63M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 5,760 4,068 $2.10M
70450 Computed tomography, head or brain; without contrast material 3.1% 9,096 6,979 $1.53M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.2% 8,609 7,983 $1.09M
71045 Radiologic examination, chest; single view 1.8% 22,780 16,847 $898K
96375 Therapeutic injection; each additional sequential IV push 1.4% 12,410 10,609 $706K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.3% 1,955 1,745 $652K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 12,661 11,133 $588K
210 more codes
C1776 Joint device (implantable) 1.2% 1,973 $567K
71046 Radiologic examination, chest; 2 views 1.0% 9,557 $514K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 1,879 $490K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 21,177 $482K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,083 $477K
72125 Computed tomography, cervical spine; without contrast material <1% 2,858 $423K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 951 $375K
G0378 Hospital observation service, per hour <1% 4,025 $364K
80053 Comprehensive metabolic panel <1% 58,010 $304K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,216 $287K
72131 <1% 1,668 $281K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,982 $270K
96361 Intravenous infusion, hydration; each additional hour <1% 8,188 $264K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,221 $242K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 10,903 $235K
85027 <1% 52,997 $208K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 10,022 $192K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 8,365 $180K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 17,164 $160K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 279 $154K
76830 Ultrasound, transvaginal <1% 1,344 $148K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,854 $141K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,817 $139K
81025 <1% 19,046 $137K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,535 $121K
76801 <1% 1,241 $118K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,034 $118K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,986 $116K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,276 $104K
J7120 Ringers lactate infusion, up to 1000 cc <1% 10,392 $98K
84484 <1% 14,181 $96K
93971 <1% 915 $95K
85730 <1% 14,120 $83K
80048 Basic metabolic panel (calcium, ionized) <1% 12,993 $75K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 18,410 $72K
74018 <1% 2,568 $72K
81001 <1% 19,224 $70K
87430 <1% 13,210 $67K
73630 <1% 2,815 $65K
83880 <1% 4,721 $64K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,889 $60K
41899 Unlisted procedure, dentoalveolar structures <1% 929 $59K
73610 <1% 2,718 $59K
64721 <1% 143 $58K
88304 <1% 885 $57K
96376 <1% 2,075 $56K
73130 <1% 2,286 $54K
36000 <1% 877 $53K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,501 $52K
74022 <1% 1,272 $51K
83690 <1% 17,069 $51K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,446 $51K
73030 <1% 2,113 $51K
73562 <1% 2,227 $50K
81003 <1% 12,932 $49K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 225 $47K
93975 <1% 290 $46K
12001 <1% 364 $43K
J7030 Infusion, normal saline solution , 1000 cc <1% 13,382 $40K
D7140 Extraction, erupted tooth or exposed root <1% 975 $39K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 539 $39K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 14 $38K
85610 <1% 14,973 $38K
72110 <1% 759 $36K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,109 $36K
27447 <1% 12 $36K
97161 <1% 1,191 $36K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,064 $35K
D2930 Prefabricated stainless steel crown - primary tooth <1% 1,999 $35K
70486 <1% 231 $32K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 127 $29K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 783 $27K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 173 $27K
87040 <1% 3,507 $27K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 583 $26K
J2550 Injection, promethazine hcl, up to 50 mg <1% 5,493 $25K
73110 <1% 1,212 $24K
85379 <1% 4,884 $23K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,808 $22K
83735 <1% 6,191 $22K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,258 $22K
87807 <1% 4,564 $21K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,571 $21K
87081 <1% 8,080 $21K
84443 Thyroid stimulating hormone (TSH) <1% 2,623 $20K
J3490 Unclassified drugs <1% 2,873 $19K
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,170 $18K
88312 <1% 672 $18K
86900 <1% 4,472 $18K
87088 <1% 4,818 $17K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,462 $17K
87070 <1% 5,332 $17K
83605 <1% 2,842 $16K
84703 <1% 3,331 $15K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,609 $15K
C1769 Guide wire <1% 464 $15K
D3110 <1% 355 $14K
86850 <1% 3,167 $13K
87186 <1% 2,535 $13K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 156 $13K
64447 <1% 108 $13K
87077 <1% 3,178 $13K
94664 <1% 990 $12K
C9399 Unclassified drugs or biologicals <1% 477 $12K
84702 <1% 2,323 $12K
36415 Collection of venous blood by venipuncture <1% 3,866 $12K
73090 <1% 548 $12K
10060 <1% 58 $11K
12011 <1% 91 $11K
80061 Lipid panel <1% 925 $10K
90715 <1% 1,510 $10K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,290 $10K
73080 <1% 447 $10K
D1351 Sealant - per tooth <1% 568 $10K
73590 <1% 429 $10K
87205 <1% 1,427 $9K
71101 <1% 257 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 1,781 $8K
73502 <1% 357 $8K
86901 <1% 4,129 $8K
82150 <1% 1,811 $7K
72100 <1% 494 $7K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,140 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,247 $7K
80320 <1% 1,128 $7K
74019 <1% 188 $6K
86140 <1% 1,766 $6K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,208 $5K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 133 $5K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 21 $5K
D2391 Resin-based composite - one surface, posterior, primary or permanent <1% 276 $5K
82550 <1% 675 $5K
72050 <1% 93 $5K
73564 <1% 189 $5K
J2800 Injection, methocarbamol, up to 10 ml <1% 894 $4K
84145 <1% 392 $4K
70496 <1% 13 $4K
72072 <1% 98 $4K
C2625 Stent, non-coronary, temporary, with delivery system <1% 18 $3K
85651 <1% 1,013 $3K
82077 <1% 635 $3K
73700 <1% 18 $3K
82803 <1% 256 $3K
73140 <1% 109 $3K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 302 $3K
97165 <1% 72 $2K
D1208 Topical application of fluoride, excluding varnish <1% 110 $2K
80074 <1% 59 $2K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 113 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 101 $2K
J2060 Injection, lorazepam, 2 mg <1% 522 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 231 $2K
72040 <1% 75 $2K
12002 <1% 13 $2K
82553 <1% 207 $2K
70498 <1% 12 $2K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 283 $2K
72128 <1% 14 $2K
80329 <1% 109 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,727 $1K
J0780 Injection, prochlorperazine, up to 10 mg <1% 409 $1K
88307 <1% 13 $1K
D2740 Crown - porcelain/ceramic <1% 239 $1K
29125 <1% 17 $1K
93017 <1% 14 $1K
29826 <1% 13 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 29 $1K
64415 <1% 29 $1K
A6223 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing <1% 38 $1K
C9113 Injection, pantoprazole sodium, per vial <1% 129 $1K
36600 <1% 119 $945.85
76870 <1% 28 $932.62
J1815 Injection, insulin, per 5 units <1% 548 $925.91
J2470 Injection, pantoprazole sodium, 40 mg <1% 149 $904.50
84439 <1% 168 $715.47
86308 <1% 327 $697.41
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 16 $694.64
77067 Screening mammography, bilateral, including computer-aided detection <1% 13 $685.19
D3120 <1% 45 $637.32
G0008 Administration of influenza virus vaccine <1% 27 $637.01
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 14 $608.44
J2704 Injection, propofol, 10 mg <1% 437 $561.59
72170 <1% 17 $561.43
J1650 Injection, enoxaparin sodium, 10 mg <1% 45 $536.46
73552 <1% 17 $470.40
A9270 Non-covered item or service <1% 95 $458.42
J1630 Injection, haloperidol, up to 5 mg <1% 195 $361.44
J7050 Infusion, normal saline solution, 250 cc <1% 211 $338.83
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 194 $296.71
82607 <1% 13 $218.51
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 87 $210.01
82360 <1% 16 $167.31
J1030 Injection, methylprednisolone acetate, 40 mg <1% 43 $128.08
J3370 Injection, vancomycin hcl, 500 mg <1% 37 $127.19
82272 <1% 54 $109.81
86317 <1% 14 $108.19
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 44 $100.38
84100 <1% 45 $97.26
97116 <1% 16 $78.95
84436 <1% 15 $76.48
80143 <1% 15 $70.92
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 13 $44.84
J7999 Compounded drug, not otherwise classified <1% 270 $29.14
90686 <1% 17 $26.46
J1171 Injection, hydromorphone, 0.1 mg <1% 50 $23.65
J3535 Drug administered through a metered dose inhaler <1% 60 $14.14
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 22 $9.97
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 13 $5.03
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 90 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 544 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDALTON, COURTNEY (CFO)